On April 2, following Tilray's latest quarterly earnings release, Roth Capital's William Kirk issued his latest take on the ...
Or is it just a value trap?
Tilray Brands stock price crashed to its lowest level since August last year despite the recent US policy change that opened ...
Tilray CEO Irwin Simon sees a future where cannabis is treated like other medicine: prescribed by doctors and tailored to ...
That's how much Tilray Brands (NASDAQ: TLRY) shares have plunged. Such a dismal performance tends to scare off some investors ...
Why rescheduling excitement proved short-lived. To some degree, there may have been "buy the rumor, sell the news" at play in ...
6d
Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime Soon
Marijuana rescheduling may have taken place in the U.S., but that doesn't mean legalization will happen anytime soon.
Every cannabis rally starts the same way: A politician floats reform, stocks rip 15% to 20% in hours, and retail chases the "next green rush." Tilray Brands (NASDAQ: TLRY) just lived the script again, ...
The 12-month Deal Also Includes Seasonal Festival Support in London and a Permanent Live Venue ELLON, Scotland, May 05, 2026 ...
Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading relatively flat in the premarket session on Wednesday. The firm has announced a product line expansion through its subsidiary, High Park Holdings ...
Although the cannabis industry celebrated "4/20 Day" earlier this week, Tilray Brands' (NASDAQ: TLRY) shareholders haven't ...
Tilray remains focused on disciplined execution, advancing innovation, and expanding access to high-quality care as the global medical cannabis market continues to evolve.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results